Effects of catecholamine releasing agents on synaptosomal dopamine biosynthesis: multiple pools of dopamine or multiple forms of tyrosine hydroxylase.
D000818:Animals; D002395:Catecholamines / Q000378:metabolism*; D003342:Corpus Striatum / Q000648:ultrastructure*; D003913:Dextroamphetamine / Q000494:pharmacology; D004296:Dopa Decarboxylase / Q000378:metabolism; D004298:Dopamine / Q000096:biosynthesis*; D066298:In Vitro Techniques; D008297:Male; D009526:Nialamide / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013574:Synaptosomes / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D014439:Tyramine / Q000494:pharmacology; D014443:Tyrosine / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism*; D010136:p-Hydroxyamphetamine / Q000494:pharmacology; D010137:p-Hydroxynorephedrine / Q000494:pharmacology
D002395:Catecholamines; D014443:Tyrosine; D010137:p-Hydroxynorephedrine; D012110:Reserpine; D010293:Pargyline; D014446:Tyrosine 3-Monooxygenase; D004296:Dopa Decarboxylase; D010136:p-Hydroxyamphetamine; D009526:Nialamide; D003913:Dextroamphetamine; D004298:Dopamine; D014439:Tyramine